| Dalbavancin for the management of gram-positive osteomyelitis: effectiveness and potential utility TA Almangour, GK Perry, CM Terriff, AA Alhifany, KS Kaye Diagnostic Microbiology and Infectious Disease 93 (3), 213-218, 2019 | 70 | 2019 |
| Multidrug-resistant and extensively drug-resistant enterobacteriaceae: prevalence, treatments, and outcomes–a retrospective cohort study H Alkofide, AM Alhammad, A Alruwaili, A Aldemerdash, TA Almangour, ... Infection and Drug Resistance, 4653-4662, 2020 | 69 | 2020 |
| Covid-19 vaccination-related sentiments analysis: a case study using worldwide twitter dataset AA Reshi, F Rustam, W Aljedaani, S Shafi, A Alhossan, Z Alrabiah, ... Healthcare 10 (3), 411, 2022 | 41 | 2022 |
| Multiple weekly dalbavancin dosing for the treatment of native vertebral osteomyelitis caused by methicillin-resistant Staphylococcus aureus: a case report TA Almangour, V Fletcher, M Alessa, AA Alhifany, D Tabb The American Journal of Case Reports 18, 1315, 2017 | 40 | 2017 |
| Ceftazidime-avibactam versus colistin for the treatment of infections due to carbapenem-resistant Enterobacterales: a multicenter cohort study TA Almangour, L Ghonem, A Aljabri, A Alruwaili, M Al Musawa, N Damfu, ... Infection and drug resistance, 211-221, 2022 | 31 | 2022 |
| Dalbavancin for the management of osteomyelitis: a major step forward? TA Almangour, AA Alhifany Journal of Antimicrobial Chemotherapy 75 (10), 2717-2722, 2020 | 22 | 2020 |
| Efficacy and safety of eravacycline: A meta-analysis K Eljaaly, JK Ortwine, M Shaikhomer, TA Almangour, M Bassetti Journal of Global Antimicrobial Resistance 24, 424-428, 2021 | 21 | 2021 |
| Dalbavancin versus standard of care for the treatment of osteomyelitis in adults: a retrospective matched cohort study TA Almangour, GK Perry, AA Alhifany Saudi Pharmaceutical Journal 28 (4), 460-464, 2020 | 20 | 2020 |
| Evaluating the effect of antibiotics sub-inhibitory dose on Pseudomonas aeruginosa quorum sensing dependent virulence and its phenotypes FS Aleanizy, FY Alqahtani, EK Eltayb, N Alrumikan, R Almebki, ... Saudi Journal of Biological Sciences 28 (1), 550-559, 2021 | 19 | 2021 |
| Work readiness scale for pharmacy interns and graduates: A cross-sectional study SSA Abuhussain, ME Elrggal, AK Salamatullah, AA Althobaity, AF Alotaibi, ... Saudi Pharmaceutical Journal 29 (9), 976-980, 2021 | 18 | 2021 |
| Effectiveness and safety of ceftriaxone compared to standard of care for treatment of bloodstream infections due to methicillin-susceptible Staphylococcus aureus: a systematic … YS Alsowaida, G Benitez, K Bin Saleh, TA Almangour, F Shehadeh, ... Antibiotics 11 (3), 375, 2022 | 15 | 2022 |
| Ceftolozane-tazobactam vs. colistin for the treatment of infections due to multidrug-resistant Pseudomonas aeruginosa: a multicentre cohort study TA Almangour, A Aljabri, M Al Musawa, A Almohaizeie, S Almuhisen, ... Journal of Global Antimicrobial Resistance 28, 288-294, 2022 | 15 | 2022 |
| Aerosolized plus intravenous colistin vs intravenous colistin alone for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria: A retrospective … TA Almangour, A Alruwaili, R Almutairi, A Alrasheed, AA Alhifany, ... International Journal of Infectious Diseases 108, 406-412, 2021 | 14 | 2021 |
| Comparing the efficacy and safety of faecal microbiota transplantation with bezlotoxumab in reducing the risk of recurrent Clostridium difficile infections: a systematic review … AA Alhifany, AR Almutairi, TA Almangour, AN Shahbar, I Abraham, ... BMJ open 9 (11), e031145, 2019 | 14 | 2019 |
| Ceftolozane–tazobactam for the treatment of multidrug-resistant Pseudomonas aeruginosa pneumonia in a patient receiving intermittent hemodialysis MA Alessa, TA Almangour, A Alhossan, MA Alkholief, M Alhokail, ... The Bulletin of the American Society of Hospital Pharmacists 75 (9), e184-e188, 2018 | 14 | 2018 |
| Ceftolozane-Tazobactam versus ceftazidime-avibactam for the treatment of infections caused by multidrug-resistant Pseudomonas aeruginosa: a multicenter cohort study TA Almangour, L Ghonem, D Alassiri, A Aljurbua, M Al Musawa, A Alharbi, ... Antimicrobial Agents and Chemotherapy 67 (8), e00405-23, 2023 | 13 | 2023 |
| Polymyxins for the treatment of lower respiratory tract infections: lessons learned from the integration of clinical pharmacokinetic studies and clinical outcomes TA Almangour, E Garcia, Q Zhou, A Forrest, KS Kaye, J Li, T Velkov, ... International journal of antimicrobial agents 57 (6), 106328, 2021 | 13 | 2021 |
| Inhaled colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria: A real-life experience in tertiary care hospitals in Saudi Arabia TA Almangour, B Alenazi, L Ghonem, AA Alhifany, BA Aldakheel, ... Saudi Pharmaceutical Journal 28 (8), 1009-1013, 2020 | 13 | 2020 |
| Association between graduates' factors and success rate on the Saudi Pharmacist Licensure Examination: A single-Institution cross-sectional study AA Alhifany, FA Almalki, YM Alatawi, LA Basindowh, SS Almajnoni, ... Saudi Pharmaceutical Journal 28 (12), 1830-1833, 2020 | 12 | 2020 |
| The influence of demographics on influenza vaccine awareness and hesitancy among adults visiting educational hospital in Saudi Arabia AA Alzeer, LA Alfantoukh, A Theneyan, FB Eid, TA Almangour, ... Saudi Pharmaceutical Journal 29 (2), 188-193, 2021 | 10 | 2021 |
